Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,140.00    9.50 (0.84%)
Bid:
1,137.00
Ask:
1,137.50
Spread: 0.50 (0.044%)
Market Cap: £9.61b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

20 Aug 2025 07:00

RNS Number : 9816V
Smith & Nephew Plc
19 August 2025
 

SMITH & NEPHEW PLC

 

19 August 2025

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

i. PARTIAL VESTING OF AWARDS MADE UNDER THE RESTRICTED SHARE PLAN 2024

 

On 19 August 2025, the Company received notification of the following transactions in US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") following the vesting of awards under the Smith & Nephew Restricted Share Plan 2024. A number of shares were sold to cover taxation obligations arising on the vesting of the awards.

 

 The award was granted under the Smith & Nephew plc Restricted Share Plan 2024 on 16 August 2024 andvest in three equal tranches on the first, second and third anniversary of the award, contingent on a reasonable judgement underpin being met as determined by the Remuneration Committee.

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

Smith & Nephew plc Ordinary Shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Partial vesting on 18 August 2025 of award granted on 16 August 2024 under the Smith & Nephew plc Restricted Share Plan 2024, and subsequent sale to cover tax liability..

Date of Transaction

2025 - 08 - 18

Place of Transaction

London Stock Exchange (XLON)

 

 

Name

(Position)

Status

Price (s)

Volume(s)

Aggregated information

Deepak Nath

(Chief Executive Officer)

Director

£13.510669

43,839 (of which 18,007 were sold and 25,832 were retained.)

N/A Single Transaction

 

 

ii. NED SHARE PURCHASE:

 

On 18 August 2025 the following American Depository Receipts (the "Shares") in Smith & Nephew plc (the "Company") were purchased by David King, Non-Executive Director.

 

Reason for the notification

Initial notification /Amendment

Initial notification

 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

Smith & Nephew plc SPON ADR American Depositary Shares

Identification code

ISIN: US83175M2052

Nature of the transaction

Share purchase

Date of Transaction

2025 - 08 - 18

Place of Transaction

New York Stock Exchange (XNYS)

Name

Director / PDMR

Price

Volume

Aggregated information

David King

Non-Executive Director

$36.3143

2,800

N/A Single Transaction

 

 

Helen Barraclough

Company Secretary

Smith & Nephew plc

Tel: +44 (0)1923 477100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFFTTRIALIE
Date   Source Headline
25th Feb 20257:00 amRNSFinal Results
12th Feb 20257:11 amRNSBlock listing Interim Review
6th Feb 20257:00 amRNSNotice of Results
3rd Feb 202510:27 amRNSTotal Voting Rights
14th Jan 20257:00 amRNSDirectorate Change
2nd Jan 202512:51 pmRNSTotal Voting Rights
20th Dec 20249:46 amRNSDirector/PDMR Shareholding
16th Dec 202411:50 amRNSHolding(s) in Company
12th Dec 20249:53 amRNSHolding(s) in Company
11th Dec 20249:03 amRNSHolding(s) in Company
9th Dec 20243:00 pmRNSDirector/PDMR Shareholding
6th Dec 20247:00 amRNSDirector Share Award vest and sale to cover tax
5th Dec 20243:35 pmRNSHolding(s) in Company
5th Dec 20247:00 amRNSHolding(s) in Company
4th Dec 20248:43 amRNSHolding(s) in Company
2nd Dec 202411:30 amRNSTotal Voting Rights
12th Nov 20247:00 amRNSDirector/PDMR Shareholding
11th Nov 20244:45 pmRNSDirector/PDMR Shareholding
1st Nov 20243:44 pmRNSDirector/PDMR Shareholding
1st Nov 20242:30 pmRNSTotal Voting Rights
31st Oct 20247:00 amRNSSmith+Nephew Third Quarter 2024 Trading Report
24th Oct 20247:00 amRNSSterling Amount of Dividend
16th Oct 20247:00 amRNSNotice of Results
1st Oct 20243:44 pmRNSTotal Voting Rights
27th Sep 202412:23 pmRNSChange to Directors' Role and Responsibilities
24th Sep 20249:00 amRNSDirector/PDMR Shareholding
19th Sep 20243:50 pmRNSDirector/PDMR Shareholding
17th Sep 20242:27 pmRNSDirector/PDMR Shareholding
13th Sep 20243:16 pmRNSDirector/PDMR Shareholding
2nd Sep 20244:11 pmRNSTotal Voting Rights
30th Aug 202410:38 amRNSDirector/PDMR Shareholding
16th Aug 20249:32 amRNSDirector/PDMR Shareholding
14th Aug 20241:14 pmRNSDirector/PDMR Shareholding
14th Aug 202411:05 amRNSDirector/PDMR Shareholding
12th Aug 20247:00 amRNSAdoption of Remuneration Policy and RSP
7th Aug 20247:00 amRNSDirector/PDMR Shareholding
5th Aug 202412:08 pmRNSBlock listing Interim Review
1st Aug 202411:09 amRNSTotal Voting Rights
1st Aug 20247:00 amRNSHalf-year Report
12th Jul 20247:00 amRNSDirector/PDMR Shareholding
9th Jul 20247:00 amRNSNotice of Results
4th Jul 20247:00 amRNSTR1: Notification of Major Holdings
3rd Jul 20247:00 amRNSTR1: Notification of Major Holdings
1st Jul 20244:22 pmRNSTotal Voting Rights
3rd Jun 20242:03 pmRNSTotal Voting Rights
30th May 20246:17 pmRNSDirector/PDMR Shareholding
24th May 20244:37 pmRNSDirector/PDMR Shareholding
22nd May 20244:23 pmRNSDirector/PDMR Shareholding
21st May 20249:52 amRNSDirector/PDMR Shareholding
9th May 20247:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.